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   We present the first application of the hypothesis-rich mathematical theory (1) to genome-
wide association data. The Hamza et al.  (2) late-onset sporadic Parkinson's disease genome-
wide association study dataset was analyzed. We found a rare, coding, non-synonymous SNP 
variant  in  the  gene  DZIP1 that  confers  increased  susceptibility to  Parkinson's  disease.  The 
association of DZIP1 with Parkinson's disease is consistent with a Parkinson's disease stem-cell 
ageing theory (1).
Introduction
   Familial genetic linkage studies have associated six genes with Mendelian inheritable forms of 
Parkinson's disease (PD) (3; 4). However, these monogenic forms account for fewer than 10% 
of PD cases. Further, they lead mostly to juvenile or early onset forms of PD (before age 50). 
Given that no decisive environmental causative factors have been found either, the etiology of 
late-onset PD (comprising over 90% of all PD cases) remains essentially undetermined. A range 
of  hypotheses  are  being  explored  (5;  6;  7;  8;  9;  10).  We have proposed the  theory that  i) 
sporadic  PD is  best  defined  as  a  characteristic  deviation  from normality  in  the  expression 
program of a cell (the PD-state) and ii) this PD-state can originate as a case of hematopoietic 
stem-cell program defect (1).
   At present, considerable efforts are focused on finding differential genetic susceptibility to 
late-onset  PD via  the  genome-wide  association  study (GWAS)  (11).  In  a  GWAS,  a  set  of 
patients and controls is genotyped at known SNP sites in the human genome. Mathematically, 
this assigns individuals to locations within a high-dimensional SNP space (Figure 1). Genetic 
susceptibilities are inferred from statistically significant differences in the placement of patients 
and  controls  in  this  SNP space.  Large  enough differential  disease  risks  constitute  practical 
predictive  genetic  markers.  So  far  though,  susceptibilities  found  have  been  typically  weak 
(some  85% of  trait  associated  SNPs  reported  have  an  odds  ratio in  the  0.5-2  range)  (12). 
Nonetheless, such findings can still be invaluable as indicators of the involvement of particular 
genes or biological processes in the disease mechanics.  As of today,  GWASs have reported 
about a dozen, modest effect (odds ratio in the 0.5-2 range), susceptibility loci for PD (2; 13; 14; 
15; 16; 17; 18; 19; 20; 21).
   The hypothesis-free paradigm currently dominates GWAS statistical data analysis (11). We 
have previously described why this is a poor choice (1). Biological knowledge and insightful 
hypotheses are as crucial in the analysis of a GWAS as they are in the analysis of any classical 
biological experiment. The alternative hypothesis-rich mathematical theory recognizes this fact 
and allows biological thought to maximize statistical power (1).  Key in the approach is the 
concept of Rational Class (RC), a set of candidate laws (markers in the GWAS context) that 
share an underlying common rationale.
   In this article, we analyze the late-onset sporadic PD GWAS dataset of Hamza et al. (2), under 
the hypothesis-rich framework (the late-onset, sporadic qualifier will be henceforth subsumed) 
(1; 22). In the Methods section, the focus is on describing the RCs constructed specifically for 
this  PD  GWAS  analysis.  Findings  are  summarized  in  the  Results section.  Finally,  in  the 
Discussion section, we review relevant biological information to contextualize our findings.
Methods
   We analyzed the GWAS dataset of Hamza et al. (2), consisting of 1986 control subjects and 
2000 sporadic late-onset PD patients. All individuals were Americans of self-reported European 
ancestry. As in any GWAS, a concern is the presence of population structure in the cohort data 
(23).  Likely the  European  population,  due  to  historical  and  geographical  factors,  does  not 
constitute,  mating-wise,  a  single  uniformly  mixed  population.  Now,  suppose  the  existing 
subpopulations have distinct susceptibilities to PD. This could be due to differences in genetic 
background,  culture (e.g.,  diet),  or  physical  environment.  Regardless,  a genetic marker of  a 
subpopulation (e.g., a SNP variant typical of a subpopulation) would then effectively mark a 
distinct susceptibility to PD. This poses a problem, in that we would like to interpret markers as 
having a causative effect on PD susceptibility, which clearly would not be the case here. The 
issue may also arise merely by study recruitment centers in areas with distinct subpopulations 
not enrolling identical ratios of PD to control subjects. Note that although for simplicity we 
allude above to discrete subpopulations, generically the mixing makeup will have a continuous 
character.
   To analyze the dataset of Hamza et al., we used the SNP space coordinate system shown in 
Figure 1. The relative overall location of individuals in SNP space (Euclidean distance wise) 
reflects the cohort population structure. Namely, relative locations are consistent with parental 
country of origin for those subjects that reported such information and for whom both parents 
had  a  common  origin.  This  is  visually  clear  upon  a  change  of  coordinates  to  principal 
component coordinates (Figure 2).
   A variety of methods exist for mitigating the population structure problem (23; 24; 25). We 
chose to homogenize the population regarding the PD to control subject ratio, via individual 
weight knock-down. Briefly, this involves reducing the statistical weight of selected individuals 
to locally level the ratio of PD to control subjects throughout SNP space. A separate article 
describes  in  detail  both  the  method  and  its  application  to  this  particular  dataset  (26).  The 
homogenization procedure reduced the dataset to a net weight of 1904 PD patients and 1802 
controls (a 7% size reduction). This will be the reference dataset henceforth.
   We utilized the hypothesis-rich framework to investigate the dataset (1; 22). The hypothesis-
rich framework provides a  targeted search, unbiased assessment  approach to the analysis of 
GWAS data. The targeted search assertion follows from biological considerations guiding the 
statistical search for genetic susceptibility factors. Specifically, biological information enters the 
mathematical analysis via the concept of Rational Class (RC), a set of candidate genetic markers 
that share a common rationale. Yet, in spite of the biased search, an  unbiased assessment is 
obtained from a proper mathematical treatment of multiple hypotheses testing (1; 22).
   We now describe the RCs constructed for the PD GWAS problem. Throughout, recall that 
separating markers into distinct RCs can be statistically advantageous if the resulting RCs have 
different True Quality Distribution and Correlation Structures (shorthand, TQDs) (1). This can 
be the case whenever a biological rationale underlies the marker separation. On the other hand, 
RCs must be rank ordered and statistical resolution decreases with increasing rank, thus overly 
liberal RC creation is pointless (1; 22).
   A total of 23 RCs were constructed (Table 1). The first 15 RCs, containing individual SNPs, 
were based on the following factors: 
   Genomic region - we grouped SNPs by whether they fell in a coding region, in the UTR or in 
the remainder of the genome. Confirming the distinct biological roles of these regions, past 
GWASs show the incidence of trait associated SNPs in them is not uniform (11). 
   SNP allele frequencies - These frequencies are affected by the degree of selective pressure on 
the  associated  haplotypes.  Thus,  on  average,  the  character  of  SNPs  with  different  allele 
frequency ratios may be distinct.  We divided SNPs into three broad groups,  based on their 
minor variant frequency: <10%, 10-30% and >30%. Also, note that we are comparatively more 
interested in larger odds ratio markers. Given two SNP markers showing the same statistical 
significance  (ordinarily,  same  p-value),  the  one  with  the  lower  minor  variant  frequency 
necessarily  shows  a  larger  differential  trait  susceptibility  (larger  odds  ratio).  Thus,  as  an 
additional  benefit,  the  above  frequency breakdown  effectively  protects  the  search  for  rare 
variant, high odds ratio markers.
   Hematopoietic fingerprints - Given our PD working theory, the set of SNPs occurring in genes 
with a function in the hematopoietic system acquires particular relevance. We recorded 2253 
SNPs  spread  across  662  so  called  hematopoietic  fingerprint  genes  (27).  The  genes  were 
identified by Chambers et al. via global gene expression profiling of murine hematopoietic stem 
cells and their major differentiated lineages (NK-cells, T-cells, B-cells, monocytes, neutrophils 
and nucleated erythrocytes) (27). 
   Combination of the above factors yielded RCs 1 thru 15 (Table 1). In these RCs, SNPs were 
tested  for  association  with  differential  PD risk  three  separate  times,  each  time  based  on  a 
different mode of splitting the SNP space (Figure 3, 1-dimensional split modes). The dominant 
and recessive modes were motivated by their well known biological counterparts. However, a 
situation where phenotype is significantly more assured only under homogeneous alleles is also 
biologically plausible. The extreme mode accommodates these cases by excluding individuals 
with heterogeneous alleles from the statistical comparison. In every case, the null hypothesis 
was that the two regions defined by the split mode present no different susceptibility to PD. 
Statistical comparison between the two chosen regions was done via the Fisher exact test.
   RCs 16 thru 19 were based on SNP pairs. Given there are on the order of 106 SNPs, potential 
SNP pairs are on the order of 1012. A RC containing such a large number of entries is unlikely to 
have a favorable TQD (1). It is therefore fundamental to prioritize SNP pairs. We generated one 
list  of  SNP pairs based on protein-protein physical  interactions (28; 29;  30).  For every two 
interacting  proteins  on different  chromosomes,  all  SNP pairs  with  one  SNP in each  of  the 
interacting proteins  respective  coding gene region were  added to  the  list.  The exclusion of 
protein  pairs  on  the  same  chromosome  excludes  pairs  of  SNPs  potentially  in  linkage 
disequilibrium. Protein-protein interactions were obtained from HPRD (~39000 interactions) 
(31). The SNP pairs were tested for association with differential PD risk five times, each time 
based on a different mode of splitting the SNP space (Figure 3, 2-dimensional split modes). In 
every case, the null hypothesis was that the two regions defined by the split mode present no 
different susceptibility to PD. Statistical comparison between the two chosen regions was done 
via the Fisher exact test. The results of the tests were assigned to RC 16 or to RC 17 depending 
on whether the associated odds ratio was smaller  or larger than 3.  Once more, this has the 
benefit of safeguarding the search for high odds ratio markers.
   A second list of SNP pairs was constructed based on the hematopoietic fingerprint genes. 
Based  on  the  expression  profiling,  Chambers  et  al.  had  further  divided  the  hematopoietic 
fingerprint genes into the following subclasses: hematopoietic stem cells, B-cells, naive T-cells, 
NK-cells,  monocytes,  granulocytes,  nucleated  erythrocytes,  differentiated  shared  fingerprint, 
lymphoid shared fingerprint and myeloid shared fingerprint (27). We generated hematopoietic 
gene  pairs  by  considering  every  possible  pairing  of  genes  within  the  same  hematopoietic 
subclass, exclusive of gene pairs in the same chromosome. The procedure described above for 
protein pairs was then applied to the hematopoietic gene pairs, thus generating RCs 18 and 19.
   RCs 20 thru 22 contained SNP tuplets generated from protein complexes (32; 33). Human 
protein complexes were obtained from the CORUM database (~1300 complexes) (34). Consider 
first RC 20, containing 2-tuplets generated from complexes of up to 4 proteins. The 2-tuplets for 
RC 20 were generated as follows:
      1. Given a complex, consider the SNPs that fall in the coding region of the protein members 
of the complex. Denote them as CSNPs. Add every possible (CSNP A, CSNP B) 2-tuplet to RC 
20, provided CSNP A and CSNP B are located in different chromosomes. 
      2. Repeat for every complex of up to 4 proteins.
   Each 2-tuplet was tested for association with differential PD risk 3 separate times, as follows:
      1. Under the dominant 1-dimensional split mode, assign a Fisher exact test based p-value to 
each CSNP in the tuplet in the standard fashion (i.e., considering the CSNP as an individual 
SNP, as in the RCs 1 thru 15). We formalize it by writing p-value = p(CSNP; dominant mode). 
      2. The p-value associated with the 2-tuplet is (max(p(CSNP A; dominant mode), p(SNP B; 
dominant mode)))2 (i.e., squared).
      3. Assign two more p-values to the tuplet, as above, but now utilizing the recessive and 
extreme 1-dimensional split modes.
   RC 21 was similar to RC 20, except that:
      1. It was based on complexes of sizes 3 thru 9.
      2. It contained 3-tuplets (CSNP A, CSNP B, CSNP C).
      3. The p-value associated with a 3-tuplet is (max(p(CSNP A; split mode), p(SNP B; split 
mode), p(SNP C; split mode)))3 (i.e., cubed).
   RC 22 was similar to RC 20, except that:
      1. It was based on complexes of sizes 4 thru 16.
      2. It contained 4-tuplets (CSNP A, CSNP B, CSNP C, CSNP D).
      3. The p-value associated with a 4-tuplet is (max(p(CSNP A; split mode), p(SNP B; split 
mode), p(SNP C; split mode), p(SNP D; split mode)))4 (i.e., to the fourth power).
   In these complex based RCs, in every case the null hypothesis is that none of the SNPs in the 
tuplet shows differential susceptibility to PD between the two regions defined by the split mode. 
The anticipation is that a complex mechanistically involved in PD may produce a tuplet (or 
tuplets) of particular low p-value under the above tuplet p-value definition. RCs 20, 21 and 22 
are kept separate to preserve potentially distinct TQDs. 
   Finally, RC 23 was based on genes in the blood gene expression signature for PD (involving 
18 genes) we developed in earlier work (1). RC 23 contained:
   1. All SNPs in the coding or UTR regions of the genes present in the expression signature.
   2. All SNP pairs, exclusive of pairs in the same chromosome, with one SNP in the coding or 
UTR regions of one expression signature gene and the other SNP in the coding or UTR region 
of a second expression signature gene.
   The individual SNPs were tested for association with differential risk of PD under the three 1-
dimensional split modes via the Fisher exact test, as in RCs 1 thru 15. The SNP pairs were 
tested for association with differential risk of PD under the five 2-dimensional split modes via 
the Fisher exact test, as in RCs 16 thru 19. All tests were placed in a single RC, given their low 
number.
 
Results
   The significant findings from the hypothesis-rich analysis of the Hamza et al. dataset are 
presented in Table 2. For these SNPs, the null hypothesis was that the two regions defined by 
the split mode (see Figure 3: 1-dimensional split modes) present no differential susceptibility to 
PD. Now, pure chance in the finite sampling of individuals from the population could create the 
false impression of differential susceptibility. The reference probability indicates the likelihood 
that such stochasticity lead to an unwarranted call (as per the hypothesis-rich framework) of 
differential susceptibility (22). For easiness of comparison, the arbitrariness in defining  odds 
ratio (given the validity of the inverse of any choice) was settled by making every odds ratio 
larger than unity. The  minor allele effect entry then indicates which region carries the greater 
risk of PD. 
   The findings of  relevant SNPs  in the SNCA region,  in the HLA-DRA region  and in the 
chromosome 17 q21.31 region (usually categorized as  the  MAPT region)  confirm previous 
GWASs observations (albeit, the diversity of SNPs found in this latter region deserves special 
attention) (2;  13;  14;  15;  16;  17;  18;  19;  20;  21).  The  novel  finding  is  the  increased 
susceptibility to PD conferred by a rare, coding, non-synonymous SNP variant in the DZIP1 
gene (Figure 4).
Discussion
   The PD working theory we put forward in previous work (1) provides a possible context for 
the connection of DZIP1 with PD found in this analysis. Therefore, we start by reviewing it. 
Firstly, PD would be defined in terms of the PD-state, a characteristic deviation from the normal 
expression program of a healthy cell. Singular cellular manifestations of PD would therefore be 
de-emphasized in  favor  of  this  systems-level  definition.  Crucially,  the  PD-state  would be a 
generic cell state, not restricted to neurons. Secondly, the PD-state would originate in a stem-
cell program defect, associated with the ageing of stem-cells. We proposed the hematopoietic 
stem-cell niche as a plausible place of origin for the PD-state, although other stem cell niches 
should not be ruled out from playing a part. Thirdly, the subsequent PD-state propagation to 
other cells  would not  occur evenly.  Propagation would be faster  to cells  more amenable to 
reprogramming (such as other stem cells or their not yet  fully differentiated progeny).  Thus 
tissues under active regeneration would be the first to be affected. Beyond PD biology, note the 
validity of this theory would signal an effective degree of communication between different 
stem-cell niches greater then what is currently accepted.
   We now describe what is known at present about the biological role of DZIP1. The gene 
DZIP1 encodes a C2H2-type zinc finger protein (35). Its acronym stands for DAZ-interacting 
protein 1, as DZIP1 was originally identified in a screen for protein interaction partners of the 
DAZ (deleted in azoospermia) protein (35). Its expression in human embryonic, stem, fetal and 
adult germ cells was thus well noted (35). Zebrafish mutants in iguana (the DZIP1 ortholog in 
Zebrafish) have been invaluable in characterizing the gene. A iguana mutant (fo10a) displayed 
ultrastructural defects in perivascular mural cell recruitment and subsequent hemorrage, thus 
linking vascular stability and DZIP1 (36). Work with Zebrafish  iguana mutants also revealed 
DZIP1 to be a component of the Hedgehog (Hh) signaling pathway (37; 38). Within the Hh 
pathway, DZIP1 acts downstream of Smoothened, modulating the activity of the Gli family of 
transcription factors (37; 38). DZIP1 has further been implicated in primary ciliogenesis and its 
role in Hh signaling may occur in this context (39; 40; 41). Hh plays a vital part in directing 
embryonic pattern formation (42).  However,  it  continues regulating adult  stem cells  beyond 
embryogenesis (43; 44). Studies have specifically implicated Hh in the adult maintenance of 
hematopoietic stem cells (45), epithelial stem cells in the gastrointestinal tract (46), neuronal 
stem cells in the subventricular zone (SVZ) and the hippocampal dentate gyrus (47; 48), hair 
follicle stem cells (49), mammary stem cells (50) and mesenchymal stem cells (51). Besides its 
role  in  neurogenesis,  Hh  has  also  shown  neurotrophic  properties,  in  particular  regarding 
dopaminergic  neuron  survival  (52;  53;  54).  Administration  of  Sonic  Hedgehog  reduced 
behavioral deficits in animal models of PD (55; 56). Nonetheless, an earlier targeted genetic 
analysis of Sonic Hedgehog in Parkinson's patients, did not find any significant mutations in 
this gene (57).
   Genetic mutations affecting the Hh pathway have been associated with an increased incidence 
of a diversity of cancers (see Merchant et  al.  (58) or  Beachy et al.  (44) for comprehensive 
listings). Under a cancer stem-cell hypothesis (59; 60) interpretation, this is consistent with the 
role  of  Hh in  adult  stem cell  homeostasis.  The aberrant  Hh signaling would contribute  the 
conversion of adult  stem cells (or  perhaps their early progeny)  into cancer stem cells,  cells 
endowed with stem-cell properties and trapped in a pathological state of constant renewal (44; 
59). Now, under our PD hypothesis, PD also originates in a stem-cell program defect. However, 
while in the cancer stem cell hypothesis the pathology progresses via physical replication of the 
cancer  stem  cells  themselves,  in  PD  we  are  proposing  propagation  solely  of  the  PD 
characteristic  expression  state  (the  PD-state)  (1).  The  PD-state  of  a  cell  could  possibly be 
physically locked in by epigenetic DNA modifications (1).
Notes
Quality control
   At the outset, a quality control procedure (61) was applied to the Hamza et al. dataset that 
excluded the following SNPs from the entire analysis:
   - SNPs with a p-value less than 10-5 under the Hardy-Weinberg test.
   - SNPs with less than a 99.9% call rate.
   The quality control was implemented using the program Plink (62). A total of 748807 SNPs 
passed the quality control.
.Figure 1.  In a genome-wide association study (GWAS), subjects are vectors in SNP space. Depicted is 
one sensible coordinate system for SNP space. Capital letters represent the major allele, lower case letters 
the minor allele. To each SNP therefore corresponds an axis with 3 admissible values (0, 1 and 2). At 
present, typical cohort sizes are in the range of 103 to 104 subjects, while the number of SNPs genotyped 
is on the order of 106. 
Figure 2.  The Hamza et al. (2) cohort data in SNP space, after a change from the Figure 1 
coordinate system to principal component coordinates (first two principal components shown). 
Color indicates the country of parental origin for subjects that reported such information and for 
whom both parents had a common origin. The plot replicates a similar figure in Hamza et al.. 
Smaller  circles  denote  individuals  with  a  lower  statistical  weight,  due  to  the  process  of 
population homogenization across SNP space regarding the PD to control subject ratio (26).
Rational 
Class 
Rank
Rational Class Description
1 coding  |  allele freq.: < 10%  |  dominant, recessive and extreme
2 coding  |  allele freq.: 10% to 20%  | dom., rec. extr.
3 coding  |  allele freq.: > 30%  | dom., rec. extr.
4 UTR  |  allele freq. < 10%  | dom., rec. extr.
5 UTR  |  allele freq.: 10% to 20%  | dom., rec. extr.
6 UTR  |  allele freq.: > 30%  | dom., rec. extr.
7 hematopoietic  |  coding  |  allele freq. < 10%  | dom., rec. extr.
8 hematopoietic  |  coding  |  allele freq.: 10% to 20%  | dom., rec. extr.
9 hematopoietic  |  coding  |  allele freq.: > 30%  | dom., rec. extr.
10 hematopoietic  |  UTR  |  allele freq. < 10%  | dom., rec. extr.
11 hematopoietic  |  UTR  |  allele freq.: 10% to 20%  | dom., rec. extr.
12 hematopoietic  |  UTR  |  allele freq.: > 30%  | dom., rec. extr.
13 non-coding/non-UTR  |  allele freq.: > 30%  | dom., rec. extr.
14 non-coding/non-UTR  |  allele freq. < 10%  | dom., rec. extr.
15 non-coding/non-UTR  |  allele freq.: 10% to 20%  | dom., rec. extr.
16 protein pairwise interactions  |  coding  |  OR > 3  | 5 split modes
17 protein pairwise interactions  |  coding  |  OR < 3  | 5 split modes
18 hematopoietic pairwise interactions | coding | OR > 3  | 5 split modes
19 hematopoietic pairwise interactions | coding | OR < 3  | 5 split modes
20 protein complexes  |  sizes 2 thru 4  |  top 2 proteins
21 protein complexes  |  sizes 3 thru 9  |  top 3 proteins
22 protein complexes  |  sizes 4 thru 16  |  top 4 proteins 
23 gene expression sig.  |  coding and UTR  |  all freqs.  |  dom., rec., extr.
Table 1. The Rational Classes (RCs) constructed to analyze the PD GWAS data.
Figure  3.  Each  graph  shows  a  manner  of  splitting  SNP space  into  two  shaded  regions. 
Differential risk of PD between the shaded regions is then ascertained (non-shaded regions are 
ignored).  1-dimensional split modes: Utilized in RCs containing single SNPs (RCs 1 thru 15 
and RC 23). 2-dimensional split modes: Utilized in RCs containing pairs of SNPs (RCs 16 thru 
19).
 
Rational 
Class
RC #2 
coding region 
minor allele freq: 10%-30%
RC #7 
hematopoietic 
coding region 
minor allele freq.< 10%
RC #15 
generic (non-coding/non-UTR) 
30% < minor allele freq. 
Gene
IMP5, MAPT, CRHR1, 
KIAA1267, C17orf69, 
NSF
DZIP1 HLA-DRA SNCA-GPRIN3, SNCA
SNP
rs12373123, rs12185235, 
17651549, rs16940665, 
12185268, kgp6408681, 
rs1052551, rs16940674, 
rs36076725, rs17652121, 
kgp3974170, rs17574604, 
kgp3365508, rs10445337, 
rs1881193, rs3583914, 
rs1052553, kgp4886152, 
rs199533
kgp1112497 rs3129822
rs356220, 
rs2736990, 
rs356168
Location
chr. 17,   q21.31 
in coding regions 
synonymous & 
non-synonymous 
substitutions
chr. 13,   q32.1 
coding region 
non-synonymous 
substitution
chr. 6,   p21.3 
intronic
chr. 4,   q22.1 
intergenic (SNCA-
GPRIN3) intronic 
(SNCA)
Minor 
allele 
frequency
19% thru 21% 0.7% 44% 40% thru 49%
Minor 
allele effect protective harmful harmful harmful
Split mode minor allele dominant minor allele dominant extreme minor allele dominant
Odds ratio 1.2 thru 1.3 4.4 1.5 1.3 thru 1.4
Reference 
probability 0.06 thru 0.09 0.03 0.04 0.04 thru 0.07
Table 2.  Summary of the findings from hypothesis-rich analysis of the Hamza et al. GWAS PD 
dataset. See the Results main text section for meaning of the entries.
Figure. 4.  Individuals in the Hamza et al. cohort carrying a copy of the rare DZIP1 allele are 
highlighted  in  SNP  space,  under  principal  component  coordinates  (first  two  principal 
components shown). No homozygous rare allele individuals were present in the dataset.
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